President Trump’s Condition: Regeneron CEO and Dr. Scott Gottlieb on POTUS Treatment
Squawk Pod5 Loka 2020

President Trump’s Condition: Regeneron CEO and Dr. Scott Gottlieb on POTUS Treatment

President Trump remains at Walter Reed National Military Medical Center, and treatments for his coronavirus diagnosis include an experimental antibody cocktail from Regeneron, dexamethasone, and Gilead’s remdesivir. CNBC’s Eamon Javers tracks the timeline of events since the President’s announcement, and CNBC’s Meg Tirrell explains the drugs in the President’s treatment plans. Former FDA Commissioner Dr. Scott Gottlieb deciphers the President’s likely condition from White House communications, and Regeneron CEO Dr. Leonard Schleifer discusses the status of the monoclonal antibody cocktail that was approved by the FDA for “compassionate use” in President Trump’s treatment.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Jaksot(1880)

5 Things to Know Before the Opening Bell 6/16/25

5 Things to Know Before the Opening Bell 6/16/25

The 5 things you need to know before the stock market opens today: Israel says it has achieved aerial superiority over Tehran, President Trump approves Nippon Steel’s $15 billion deal to acquire U.S. ...

16 Kesä 20252min

Israel & Iran: Oil, Iran’s Nuclear Program, & What’s Next 6/13/25

Israel & Iran: Oil, Iran’s Nuclear Program, & What’s Next 6/13/25

Israel’s strikes against Iran early Friday morning killed Iran’s most senior military official and the commander-in-chief of Iran’s Islamic Revolutionary Guard Corps, as well as two nuclear scientists...

13 Kesä 202541min

5 Things to Know Before the Opening Bell 6/13/25

5 Things to Know Before the Opening Bell 6/13/25

The 5 things you need to know before the stock market opens today: Israel launches strikes against Iran, investigators are searching the site of the Air India crash, a federal appeals court rules Pres...

13 Kesä 20251min

Gary Cohn & CNBC’s Disruptor 50: Gecko Robotics 6/12/25

Gary Cohn & CNBC’s Disruptor 50: Gecko Robotics 6/12/25

Gary Cohn worked in the first Trump administration as the National Economic Council Director. Today, as IBM Vice Chair, Cohn discusses the state of the economy, the U.S. dollar, inflation, and the Fed...

12 Kesä 202539min

Regeneron CEO on 23andMe & $275m in Margaritaville 6/11/25

Regeneron CEO on 23andMe & $275m in Margaritaville 6/11/25

The U.S. and China have reached a framework for a trade deal, marking progress in the London talks between both nations. Bankrupt23andMe is up for sale, and drugmaker Regeneron is at the negotiating t...

11 Kesä 202531min

5 Things to Know Before the Opening Bell 6/11/25

5 Things to Know Before the Opening Bell 6/11/25

The 5 things you need to know before the stock market opens today: Elon Musk apologizes (?), Tesla readies its robotaxi, U.S. and China trade talks hit a potential resolution, a federal appeals court ...

11 Kesä 20252min

The CDC’s Vaccine Advisors & the PA Governor on LA Protests 6/10/25

The CDC’s Vaccine Advisors & the PA Governor on LA Protests 6/10/25

As the U.S. and China continue trade talks in London, APCO Worldwide’s Jim McGregor discusses the fine line between goals to protect American industry and maintain the global tech supply chain. The fe...

10 Kesä 202537min

The Warner Brothers Discovery Split & A Big Handshake with China 6/9/25

The Warner Brothers Discovery Split & A Big Handshake with China 6/9/25

National Economic Council Director Kevin Hassett discusses the goals of the top U.S. trade negotiators as they meet their Chinese counterparts in London today. A big handshake and a short meeting will...

9 Kesä 202530min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
psykopodiaa-podcast
mimmit-sijoittaa
rss-rahapodi
rss-rahamania
ostan-asuntoja-podcast
rahapuhetta
inderespodi
rss-h-asselmoilanen
rss-lahtijat
rss-bisnesta-bebeja
herrasmieshakkerit
rss-neuvottelija-sami-miettinen
pomojen-suusta
rss-porssipuhetta
rss-laakispodi
rss-startup-ministerio
rss-paasipodi
sijoituspodi
asuntoasiaa-paivakirjat